| |
| |
|
| Insider
Information: |
Loy Bertrand |
| Relationship: |
Director |
| City: |
Acton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
345,517 |
|
|
Indirect Shares
|
420,624 |
|
|
| Direct
Value |
$34,333,566 |
|
|
|
Indirect Value
|
$1,417,503 |
|
|
| Total
Shares |
766,141 |
|
|
| Total
Value |
$35,751,069 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
|
Harvard Bioscience Inc |
HBIO |
Director |
2023-05-22 |
79,009 |
2023-05-22 |
420,624 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
31,300 |
101,800 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
117,750 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
98,501 |
550,751 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
135,850 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
149,850 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
40,948 |
586,254 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
61,458 |
622,735 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
35,100 |
184,950 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
191,550 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
223,493 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
30,868 |
626,315 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
38,665 |
664,980 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
91,000 |
91,000 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-03-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
91,000 |
534,577 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-06-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,767) |
221,726 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,100 |
249,826 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,300 |
251,126 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
42,194 |
576,771 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-09-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
101,888 |
474,883 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-09-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
101,888 |
192,888 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,300 |
272,426 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
29,760 |
504,643 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2021-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
23,428 |
528,071 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
286,826 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2021-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,401 |
288,227 |
0 |
- |
|
176 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
